background
telomer
biolog
disord
tbd
includ
rang
multisystem
diseas
character
mucocutan
symptom
bone
marrow
failur
dyskeratosi
congenita
dkc
clinic
featur
tbd
stem
deplet
crucial
stem
cell
popul
highli
prolif
tissu
result
abnorm
telomeras
function
due
wide
spectrum
clinic
present
lack
conclus
laboratori
test
may
challeng
reach
clinic
diagnosi
especi
patient
lack
pathognomon
clinic
featur
tbd
method
clinic
sequenc
perform
cohort
patient
present
variabl
immun
phenotyp
lack
molecular
diagnos
hypothesisfre
wholeexom
sequenc
we
select
absenc
compel
diagnost
hint
patient
variabl
immunolog
haematolog
condit
four
patient
belong
three
famili
detect
five
novel
variant
known
tbdcaus
gene
tert
addit
molecular
find
present
shorten
blood
cell
telomer
find
consist
display
tbd
phenotyp
address
toward
molecular
diagnosi
subsequ
clinic
followup
patient
conclus
result
strongli
support
util
wesbas
approach
routin
genet
diagnost
tbd
patient
heterogen
atyp
clinic
present
otherwis
might
remain
undiagnos
telomer
biolog
disord
tbd
telomeropathi
embodi
rang
patholog
phenotyp
ensu
abnorm
telomeras
function
first
tbd
describ
dyskeratosi
congenita
dkc
sever
inherit
multisystem
disord
character
reticul
skin
pigment
nail
dystrophi
oral
leukoplakia
bone
marrow
failur
present
cytopenia
one
hematopoiet
cell
lineag
clinic
telomer
shorten
due
prematur
senesc
stem
cell
promin
display
highli
prolifer
mucocutan
tissu
sever
clinic
featur
dkc
bone
marrow
failur
affect
major
patient
caus
prematur
mortal
addit
dkc
patient
increas
risk
malign
fatal
pulmonari
complic
immunodefici
present
dkc
known
caus
mutat
gene
associ
xlink
recess
inherit
autosom
recess
andor
domin
inherit
tert
terc
acd
parn
recent
term
dkc
use
categor
welldefin
childhood
symptom
base
phenotyp
sever
variant
dkc
manifest
hoyeraalhreidarsson
syndrom
hh
rare
disord
character
bone
marrow
failur
immunodefici
cerebr
hypoplasia
intrauterin
growth
retard
dkc
often
gone
unnot
due
delayedonset
mucocutan
find
wide
spectrum
clinic
present
lack
conclus
laboratori
test
dkc
time
make
clinic
diagnosi
challeng
exact
genet
diagnosi
dkc
essenti
due
limit
efficaci
therapeut
option
genet
anticip
common
dkc
make
time
famili
counsel
prioriti
present
studi
attest
valid
wholeexom
sequenc
we
base
approach
routin
genet
diagnost
patient
heterogen
clinic
present
suspicion
tbd
three
patient
brother
one
patient
present
vari
characterist
immunolog
hematolog
disord
identifi
monogen
variant
gene
associ
tbd
support
genotypephenotyp
correl
demonstr
shorten
blood
cell
telomer
length
studi
perform
helsinki
univers
hospit
pediatr
adult
immunodefici
unit
depart
adult
hematolog
divis
pediatr
hematologyoncolog
stem
cell
transplant
genet
analys
perform
part
clinic
workup
clinic
undiagnos
patient
diseas
phenotyp
suggest
monogen
condit
overlap
primari
immunodefici
disord
pid
character
phenotyp
studi
patient
shown
addit
file
figur
identif
alter
tbdassoci
gene
finnish
patient
retrospect
collect
clinic
data
studi
conduct
accord
principl
helsinki
declar
approv
coordin
ethic
committe
helsinki
univers
hospit
inform
consent
receiv
patient
case
children
parent
genom
dna
studi
individu
isol
peripher
blood
standard
salt
precipit
protocol
wholeexom
sequenc
we
perform
patient
detail
workflow
read
align
variant
call
provid
addit
file
briefli
sureselect
clinic
research
captur
exom
sureselect
human
exon
mb
kit
agil
santa
clara
ca
usa
use
pairedend
sequenc
perform
hiseq
hiseq
platform
illumina
san
diego
ca
usa
sequenc
read
analyz
use
version
inhous
develop
analysi
pipelin
vcp
qualiti
control
variant
identif
annovar
access
may
use
annot
predict
function
consequ
identifi
variant
sequenc
align
refer
build
human
genom
use
bwa
align
downstream
process
variant
call
perform
genom
analysi
toolkit
samtool
picard
substitut
indel
call
made
gatk
unifi
genotyp
consid
variant
minor
allel
frequenc
maf
frequenc
filter
base
data
genom
aggreg
databas
gnomad
cambridg
usa
http
gnomadbroadinstituteorg
sisu
project
http
sisufimmfi
access
may
respect
filter
accord
predict
consequ
transcript
level
select
frameshift
infram
nonsens
splice
missens
variant
variant
priorit
accord
predict
effect
protein
conserv
affect
amino
acid
silico
predict
tool
includ
annovar
pathogen
predict
accord
american
colleg
medic
genet
acmg
standard
guidelin
possibl
candid
variant
analyz
famili
cosegreg
affect
rel
due
sever
describ
inherit
model
consid
homozyg
compound
heterozyg
heterozyg
variant
identifi
candid
variant
valid
sanger
sequenc
addit
file
rel
telomer
length
rtl
determin
quantit
pcr
method
describ
cawthon
et
al
minor
modif
briefli
sampl
ng
dna
peripher
blood
leukocyt
analyz
triplic
well
separ
telomer
tel
singl
copi
gene
hbg
reaction
abi
instrument
appli
biosystem
two
separ
occas
pcr
plate
telhbg
ts
valu
calcul
method
ct
tel
ct
hbg
rtl
valu
gener
divid
sampl
ts
valu
ts
valu
refer
celllin
dna
ccrfcem
includ
run
standard
curv
refer
cell
line
dna
includ
everi
run
monitor
pcr
effici
rtl
valu
compar
normal
control
age
year
genet
screen
clinic
undiagnos
finnish
patient
identifi
five
novel
diseas
variant
tbdassoci
gene
three
patient
brother
one
patient
fig
tabl
clear
pathognomon
sign
telomeropathi
hematolog
immunolog
character
patient
summar
tabl
patient
male
nonconsanguin
famili
remit
we
search
mutat
associ
chronic
mucocutan
candidiasi
identif
novel
variant
p
earli
childhood
diagnos
vesicoureter
reflux
urinari
tract
infect
never
suffer
sever
infect
receiv
normal
vaccin
includ
mmr
earli
age
fingernail
abnorm
broke
easili
skin
reddish
easili
irrit
skin
chang
neck
upper
thorax
consist
poikiloderma
age
year
start
present
recurr
aphthou
ulcer
oral
mucosa
includ
tongu
patchi
lesion
homogen
leukoplakia
observ
dorsum
tongu
ventral
side
biopsi
epitheli
chang
compat
leukoplakia
candidiasi
found
result
immunolog
workup
slightli
decreas
concentr
cell
count
otherwis
normal
result
cytopenia
age
year
cell
found
subnorm
cell
could
confirm
retest
famili
studi
show
older
brother
index
patient
suffer
slightli
milder
skin
nail
oral
mucou
membran
abnorm
well
recurr
genit
candida
infect
genet
test
reveal
carri
variant
confirm
cosegreg
diseas
variant
inherit
mother
consist
xlink
recess
inherit
matern
grandfath
die
traumat
rememb
nail
skin
chang
well
best
knowledg
none
close
famili
suffer
solid
tumor
hematolog
malign
lung
fibrosi
peripher
blood
cytopenia
patient
daughter
nonconsanguin
parent
we
analysi
reveal
two
novel
heterozyg
variant
tert
g
p
p
segreg
analysi
famili
demonstr
patient
inherit
one
variant
parent
support
autosom
recess
inherit
born
term
smallforgestationalag
catch
normal
growth
age
two
development
delay
record
earli
infanc
later
age
four
disord
swallow
oesophag
strictur
diagnos
requir
dilat
age
mild
thrombocytopenia
macrocytosi
detect
peripher
blood
bone
marrow
show
normal
hematopoiesi
cytopenia
persist
reevalu
bone
marrow
age
year
show
featur
myelodysplasia
hypoplast
anemia
paroxysm
nocturn
hemoglobinuria
fanconi
anemia
exclud
despit
extens
immunolog
evalu
immunodefici
detect
never
present
pulmonari
nail
skin
symptom
fair
thin
hair
older
sister
old
present
symptom
none
close
rel
diagnos
cancer
classic
dkc
patient
boy
nonconsanguin
parent
analyz
we
due
immunodefici
occurr
opportunist
infect
identifi
two
novel
heterozyg
variant
c
confirm
rna
transcript
level
p
variant
rare
popul
segreg
analysi
show
one
variant
inherit
parent
support
autosom
recess
inherit
born
prematur
gestat
week
smallforgestationalag
weight
sd
height
sd
receiv
normal
vaccin
month
age
age
month
hospit
fever
pneumonia
pneumocysti
jirovecii
plu
metapneumoviru
coronaviru
detect
respiratori
secret
addit
cytomegaloviru
dnaemia
present
high
copi
number
accompani
retin
immunolog
workup
reveal
b
nk
sever
combin
immunodefici
scid
phenotyp
brain
mri
show
atroph
chang
cerebellum
microcephalia
age
month
hematopoiet
stem
cell
transplant
hsct
umbil
cord
graft
perform
due
scid
engraft
full
donor
chimer
without
sign
graftversushost
diseas
transient
cmv
reactiv
success
treat
antivir
treatment
prolong
diarrhea
preced
hsct
colitislik
symptom
continu
hsct
need
longlast
total
parenter
nutrit
otherwis
recov
immun
pulmonari
problem
abat
sign
decreas
liver
function
far
due
young
age
hsct
perform
chemotherapeut
condit
reliabl
evalu
statu
hair
skin
patient
hsct
treat
pediatr
neurologist
parent
receiv
genet
counsel
known
famili
histori
immunodefici
malign
due
identif
variant
gene
associ
defect
telomer
function
analyz
length
telomer
four
patient
patient
show
short
rel
telomer
length
percentil
compar
healthi
control
age
fig
integr
genet
find
clinic
phenotyp
decreas
telomer
length
led
diagnosi
dkc
bone
marrow
failur
hoyeraalhreidarsson
syndrom
present
studi
use
hypothesisfre
we
identifi
diseas
variant
telomeropathyassoci
gene
four
patient
clinic
phenotyp
rang
mild
sign
dkc
scid
telomeropathi
includ
rang
patholog
condit
result
defect
telomer
biolog
great
variat
term
clinic
sever
age
diagnosi
tbd
patient
display
classic
triad
symptom
skin
pigment
nail
dystrophi
oral
leukoplakia
thu
lack
pathognomon
sign
dkc
patient
bone
marrow
failur
immunodefici
may
present
symptom
sever
phenotyp
variant
dkc
hoyeraalhreidarsson
syndrom
hh
may
clinic
present
scid
children
howev
biallel
mutat
hhscaus
gene
may
also
lead
select
nk
defici
wide
phenotyp
variat
may
contribut
diagnost
delay
especi
adult
patient
seen
diagnos
age
year
addit
divers
clinic
present
mutat
variou
gene
caus
telomereshorten
may
manifest
increas
sever
shorter
telomer
success
gener
process
call
genet
anticip
thu
tbd
patient
mild
phenotyp
may
offspr
potenti
manifest
earli
life
bone
marrow
failur
sever
immunolog
aberr
aggrav
complic
like
rapid
deterior
pulmonari
function
due
increas
sever
gener
diseasecaus
variant
tend
eventu
disappear
pedigre
like
reason
finnish
famili
telomeropathi
includ
studi
appear
rare
novel
mutat
fulli
opposit
major
rare
recess
diseas
seen
finland
typic
caus
one
major
finnish
founder
mutat
enrich
popul
therefor
possibl
novel
variant
need
consid
patient
tbd
suspicion
known
patholog
variant
found
targetedvari
approach
due
heterogen
clinic
present
allel
heterogen
patient
clinic
suspicion
telomeropathi
could
benefit
investig
we
applic
ngsbase
assay
success
demonstr
studi
one
patient
within
cohort
present
classic
skin
nail
mucos
find
suggest
dkc
furthermor
one
patient
genet
analysi
immedi
produc
final
molecular
diagnosi
hh
initi
observ
clinic
featur
scid
could
led
use
repeat
mistarget
assay
identifi
causal
variant
identif
variant
tbdassoci
gene
patient
show
seemingli
distinct
immun
haematolog
condit
emphas
potenti
we
discern
atyp
trait
monogen
syndrom
broaden
phenotyp
spectrum
diseas
addit
provid
prompt
molecular
diagnosi
we
also
allow
screen
secondari
caus
variant
potenti
explain
untyp
phenotyp
featur
importantli
we
combin
telomer
length
measur
enabl
identif
novel
tbd
caus
gene
defect
given
novel
tbdcaus
gene
yet
discov
genet
heterogen
measur
telomer
length
also
consid
screen
undiagnos
patient
clinic
featur
compat
tbd
quantit
pcrbase
assay
use
studi
costeffici
mean
complement
diagnost
patient
bone
marrow
failur
primari
immunodefici
genet
point
view
earli
diagnosi
tbd
critic
counsel
provid
famili
diseasecaus
mutat
identifi
assess
allel
segreg
systemat
recommend
entir
famili
particularli
case
xlink
tbd
exemplifi
diseas
may
carri
silent
femal
transmit
next
gener
absenc
prenat
diagnosi
also
women
may
present
symptom
due
skew
xinactiv
therefor
studi
famili
indic
clinic
point
view
treat
hematologist
consid
possibl
tbd
evalu
patient
bone
marrow
failur
appar
unexplain
cytopenia
myelodysplast
syndrom
emerg
earli
age
even
absenc
classic
mucocutan
triad
prompt
diagnosi
telomeropathi
case
atyp
present
tbd
like
aplast
anemia
import
bring
attent
need
monitor
possibl
aris
tbdrelat
organ
complic
addit
immunosuppress
therapi
unlik
benefici
patient
may
profit
treatment
anabol
steroid
aim
improv
cell
count
furthermor
patient
sever
bone
marrow
failur
evalu
hematopoiet
stem
cell
transplant
knowledg
exact
genet
diagnosi
help
plan
prepar
regimen
followup
hsct
well
choos
donor
among
famili
member
use
hypothesisfre
we
identifi
novel
diseas
variant
tbdassoci
gene
clinic
undiagnos
finnish
patient
use
we
help
clinician
provid
prompt
diagnosi
telomeropathi
absenc
classic
pathognomon
sign
highlight
relev
achiev
molecular
diagnosi
subsequ
accur
genet
counsel
sinc
effect
treatment
lack
tbd
addit
file
figur
categor
clinic
phenotyp
patient
studi
dataset
n
patient
categori
defin
accord
primari
immunodefici
diseas
committe
report
